Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Dowlati
A. Dowlati
Columbia University
Pemetrexed
Gemcitabine
Chemotherapy
Medicine
Pathology
5
Papers
135
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM)
2016
Journal of Clinical Oncology
George R. Simon
Pasi A. Jänne
C. J. Langer
V. Clarie
A. Dowlati
Shirish M. Gadgeel
Karen Kelly
Z. Ye
Coleman K. Obasaju
K. E. Hood
Hedy L. Kindler
Show All
Source
Cite
Save
Citations (0)
Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial
2008
Journal of Clinical Oncology
George R. Simon
Claire F. Verschraegen
Pasi A. Jänne
Corey J. Langer
A. Dowlati
Shirish M. Gadgeel
Karen Kelly
Gregory P. Kalemkerian
Anne M. Traynor
Guangbin Peng
John Gill
Coleman K. Obasaju
Hedy L. Kindler
Show All
Source
Cite
Save
Citations (83)
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
2008
Journal of Clinical Oncology
Pasi A. Jänne
George R. Simon
Corey J. Langer
Robert N. Taub
A. Dowlati
Panos M. Fidias
Matthew J. Monberg
Coleman K. Obasaju
Hedy L. Kindler
Show All
Source
Cite
Save
Citations (43)
An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
2005
Journal of Clinical Oncology
Pasi A. Jänne
George R. Simon
C. J. Langer
Robert N. Taub
A. Dowlati
P. Fidias
L. Bloss
Z. Ye
Coleman K. Obasaju
Hedy L. Kindler
Show All
Source
Cite
Save
Citations (7)
1